U.S. negotiators delivered some solid gains for U.S. farmers, particularly by prying open a little more of Canada’s tightly controlled dairy market, especially dry milk. And Canada also bent to U.S. demands for 10 years of patent exclusivity protection for biologic drugs, two more years than what was negotiated in the Trans-Pacific Partnership. Drugmakers sought the longer exclusivity term, but consumer advocates argued that the extended period would hurt patients by delaying the marketing of generic drugs.

Source: Los Angeles Times October 01, 2018 17:37 UTC